Galli Massimo, Gervasoni Cristina, Ridolfo Anna Lisa, Trabattoni Daria, Santambrogio Sara, Vaccarezza Mauro, Meroni Luca, Trifirò Giuliana, Moroni Mauro, Norbiato Guido, Clerici Mario
Institute of Infectious and Tropical Diseases, University of Milan, Sacco Hospital, Milan, Italy.
AIDS. 2003 Apr;17 Suppl 1:S155-61. doi: 10.1097/00002030-200304001-00019.
To test the cytokine production of peripheral blood mononuclear cells in a group of HIV-infected women with breast enlargement and lower limb wasting while receiving antiretroviral therapy (ART) including a protease inhibitor.
Case-control study including 20 women with fat tissue alterations and 20 matched controls treated with comparable ART.
Adipose tissue alterations (ATA) were defined by increased breast size (> or = 2 bra sizes) accompanied by lower limb fat wasting. A randomly selected subset of patients underwent analyses including: dual energy X-ray absorptiometry, metabolic and endocrine assays, in vitro cytokine production testing [interferon-gamma, interleukin (IL)-2, IL-4, IL-10, IL-12, tumor necrosis factor-alpha (TNF-alpha)] after appropriate stimulation; T-cell phenotyping, T-helper function after stimulation with either tetanus toxoid, influenza antigen, allogeneic peripheral blood lymphocytes, and phytohemagglutinin. Endocrinological study included the determination of plasma concentrations of prolactin, growth hormone, testosterone, adrenocorticotropic hormone, cortisol and C-peptide.
In vitro production of IL-12 was higher (P = 0.0001), and TNF-alpha (P = 0.0093) and IL-10 (P < 0.0001) production were lower in stimulated peripheral blood mononuclear cells of ATA-positive women compared with ATA-negative women. ATA-positive women also showed a better response to tetanus toxoid (P = 0.021) and a lower median fluorescence intensity of CD14/DR (P=0.033). Plasma C-peptide values were higher in ATA-positive women compared with ATA-negative women (P = 0.033), even if in the normal range (< 4 ng/ml) in all but one of the ATA-positive patients.
HIV-1-infected women who developed breast enlargement and lower limb fat wasting while receiving ART had a favorable immunological profile with efficient IL-12 production and T-helper function, and with TNF-a production in the range of a HIV-negative reference population. These findings suggest that the rescue of some immune functions under ART may be involved in the pathogenesis of this particular adipose tissue disorder.
检测一组在接受包括蛋白酶抑制剂在内的抗逆转录病毒治疗(ART)时出现乳房增大和下肢消瘦的HIV感染女性外周血单个核细胞的细胞因子产生情况。
病例对照研究,包括20名有脂肪组织改变的女性和20名接受类似ART治疗的匹配对照。
脂肪组织改变(ATA)定义为乳房尺寸增加(≥2个胸罩尺寸)并伴有下肢脂肪消耗。随机选择一部分患者进行分析,包括:双能X线吸收法、代谢和内分泌检测、适当刺激后体外细胞因子产生检测[干扰素-γ、白细胞介素(IL)-2、IL-4、IL-10、IL-12、肿瘤坏死因子-α(TNF-α)];T细胞表型分析、用破伤风类毒素、流感抗原、同种异体外周血淋巴细胞和植物血凝素刺激后的T辅助功能。内分泌学研究包括测定血浆中催乳素、生长激素、睾酮、促肾上腺皮质激素、皮质醇和C肽的浓度。
与ATA阴性女性相比,ATA阳性女性受刺激的外周血单个核细胞中IL-12的体外产生较高(P = 0.0001),而TNF-α(P = 0.0093)和IL-10(P < 0.0001)的产生较低。ATA阳性女性对破伤风类毒素也有更好的反应(P = 0.021),且CD14/DR的中位荧光强度较低(P = 0.033)。与ATA阴性女性相比,ATA阳性女性的血浆C肽值更高(P = 0.033),尽管除一名ATA阳性患者外,所有患者的血浆C肽值均在正常范围内(< 4 ng/ml)。
在接受ART时出现乳房增大和下肢脂肪消耗的HIV-1感染女性具有良好的免疫特征,能有效产生IL-12并具有T辅助功能,且TNF-α的产生处于HIV阴性参考人群范围内。这些发现表明,ART下某些免疫功能的恢复可能参与了这种特殊脂肪组织疾病的发病机制。